Despite recent advances in the management of colorectal cancer, metastatic disease
remains challenging, and patients are rarely cured. However, a better understanding of the …

Numerous inherent and acquired genetic alterations have been demonstrated with
resistance to anti-epidermal growth factor receptor (anti-EGFR) therapy in metastatic …

The proximal and distal subsites of colorectal cancer (CRC) have distinct differences in their
embryonic origin, epidemiology, and prognosis. Therefore, they are not considered as the …

Objectives To establish and validate a radiomics model based on multiparametric magnetic
resonance imaging (MRI), and to predict microsatellite instability (MSI) status in rectal cancer …

Colorectal cancer (CRC) is one of the deadliest malignant tumors worldwide and its
prevalence is increasing in South Korea. The efficacy of combined treatment with natural …

Biological evidence suggests that vitamin D has numerous anticancer functions, but the
associations between vitamin D status and colorectal cancer (CRC) risk and survival remain …

There are well-documented racial differences in age-of-onset and laterality of colorectal
cancer. Epigenetic age acceleration is postulated to be an underlying factor. However …

Introduction Cellular immune response to cancer is known to be of great importance for
tumor control. Moreover, solid tumors influence circulating lymphocytes, which has been …

Patients with right-sided colon cancer (RCC) generally have a poorer prognosis than those
with left-sided colon cancer (LCC). We previously found that homeobox C6 (HOXC6) was …

Purpose: Well-differentiated lung neuroendocrine tumors (Lu-NET) are classified as typical
(TC) and atypical (AC) carcinoids, based on mitotic counts and necrosis. However …